These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 3299818

  • 1. Treatment of Raynaud's phenomenon with nifedipine short-term and long-term effects.
    Kallenberg CG, Wouda AA, Kuitert JJ, Tijssen J, Wesseling H.
    Vasa Suppl; 1987; 18():68-70. PubMed ID: 3299818
    [No Abstract] [Full Text] [Related]

  • 2. [Use of nifedipine in patients with Raynaud's phenomenon].
    Rozwodowska M, Polaszewska-Muszyńska M, Ukleja-Adamowicz M, Rewakowicz M, Guzowska M, Marunowska A, Jundziłł W, Wodyńska T, Ruchalski M, Strzelecki A.
    Kardiol Pol; 1987; 30 Suppl():97-105. PubMed ID: 3331405
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of the calcium channel blocker nifedipine on Raynaud's phenomenon. A controlled double blind trial.
    Sauza J, Kraus A, González-Amaro R, Alarcón-Segovia D.
    J Rheumatol; 1984 Jun; 11(3):362-4. PubMed ID: 6376801
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. DIAS rounds. Nifedipine and prazosin in Raynaud's phenomenon.
    Pisenti L, Hart LL.
    Drug Intell Clin Pharm; 1984 Mar; 18(3):213-4. PubMed ID: 6365494
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Nifedipine in Raynaud's phenomenon: relationship between immediate, short term and longterm effects.
    Kallenberg CG, Wouda AA, Kuitert JJ, Tijssen J, Wesseling H.
    J Rheumatol; 1987 Apr; 14(2):284-90. PubMed ID: 3598997
    [Abstract] [Full Text] [Related]

  • 9. Slow release nifedipine in the treatment of Raynaud's phenomenon.
    Costantini A, Martelli E, Bavera P, Agus GB.
    Int Angiol; 1987 Apr; 6(4):359-63. PubMed ID: 3330116
    [Abstract] [Full Text] [Related]

  • 10. Vibrotactile sensation and response to nifedipine dose titration in primary Raynaud's phenomenon.
    Challenor VF, Waller DG, Hayward RA, Griffin MJ, Roath OS.
    Angiology; 1989 Feb; 40(2):122-8. PubMed ID: 2644877
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Nifedipine in the treatment of idiopathic Raynaud's syndrome.
    Sarkozi J, Bookman AA, Mahon W, Ramsay C, Detsky AS, Keystone EC.
    J Rheumatol; 1986 Apr; 13(2):331-6. PubMed ID: 3723496
    [Abstract] [Full Text] [Related]

  • 13. A randomized double blind cross-over trial of nifedipine in the treatment of primary Raynaud's phenomenon.
    Corbin DO, Wood DA, Macintyre CC, Housley E.
    Eur Heart J; 1986 Feb; 7(2):165-70. PubMed ID: 3516704
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nifedipine for Raynaud's phenomenon.
    Lancet; 1983 Jan 15; 1(8316):130. PubMed ID: 6129447
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Controlled double-blind trial of the clinical effect of nifedipine in the treatment of idiopathic Raynaud's phenomenon.
    Gjørup T, Kelbaek H, Hartling OJ, Nielsen SL.
    Am Heart J; 1986 Apr 15; 111(4):742-5. PubMed ID: 3513504
    [Abstract] [Full Text] [Related]

  • 19. Nicardipine for the treatment of Raynaud's phenomena: a double blind crossover trial of a new calcium entry blocker.
    Rupp PA, Mellinger S, Kohler J, Dorsey JK, Furst DE.
    J Rheumatol; 1987 Aug 15; 14(4):745-50. PubMed ID: 3312603
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.